Positron emission tomography in the pretreatment evaluation and follow- up of non-small cell lung cancer patients treated with radiotherapy: Preliminary findings

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 4, 1996, Pages 416-421

  Hebert, Mary E ^a   Lowe, Val J ^a   Hoffman, John M ^a   Patz, Edward F ^a   Anscher, Mitchell S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

18F 2 fluoro 2 deoxy D glucose; Lung cancer; Positron emission tomography; Radiation therapy

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL OBSERVATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA IN SITU; CARCINOMA, NON-SMALL-CELL LUNG; CICATRIX; DEOXYGLUCOSE; FIBROSIS; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG DISEASES; LUNG NEOPLASMS; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0030003388     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199608000-00020     Document Type: Article

References (16)

1. Singh SK, Buonocore E, Hubner KF, Smith GT. Dynamic FDG PET in characterizing and staging lung cancer [Abstract 676]. Presented at RSNA, 1990.
2. Weber G. Enzymology of cancer cells. Part I. N Engl J Med 1977;296:486-92.
3. Weber G. Enzymology of cancer cells. Part II. N Engl J Med 1977;296:541-51.
4. Warburg O, ed. The metabolism of tumors: investigations from the Kaiser Wilhelm Institute for Biology, Berlin-Dahlem. London: Constable, 1930.
5. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-61.
6. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60:2682-9.
7. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-4.
8. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-33.
9. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med 1989;30:33-7.
10. 18-F-2 fluoro-2-deoxy-D-glucose and positron emission tomography (PET) imaging. Radiology 1993;188:487-90.
11. 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990;19:1005-10.
12. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992;17:877-81.
13. 18F] fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
14. 18F] fluoro-2-deoxy-D-glucose (a report from an EEC task group). Appl Radiat Isot 1987;38:605-10.
15. 18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection. Eur J Nucl Med 1982;7:294-7.
16. 18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-5.